Vaccine Storage and Handling are critical aspects of the vaccine supply chain, ensuring that vaccines remain safe, effective, and potent from the time they are manufactured until they are administered to individuals. Proper storage and handling procedures are essential to maintain the stability and integrity of vaccines and prevent their degradation or spoilage. Vaccines are sensitive biological products that can lose their potency if exposed to inappropriate storage conditions, such as extreme temperatures, light, or improper handling. Therefore, vaccines must be stored and transported within a specific temperature range recommended by the manufacturer, typically between 2°C and 8°C (36°F to 46°F) for most vaccines.
Specialized vaccine storage units, such as refrigerators and freezers, are used to maintain the recommended temperature range and protect vaccines from temperature fluctuations. These units should be equipped with temperature monitoring devices, such as digital data loggers or thermometers, to continuously monitor and record the temperature to ensure compliance with storage requirements. Vaccine storage units should also be properly organized to prevent overcrowding and ensure adequate air circulation around the vaccines. During transport, vaccines should be packed in insulated containers with temperature-monitoring devices to maintain the recommended temperature range. Cold chain management practices, such as using cold packs or ice packs, are employed to keep vaccines within the appropriate temperature range during transit. Proper vaccine handling procedures are also essential to prevent contamination and maintain vaccine integrity. Healthcare providers should adhere to strict hygiene practices, such as handwashing and wearing gloves, when handling vaccines to minimize the risk of contamination.
Title : A universal AI design framework and brokerage platform for democratised manufacturing of mRNA therapeutics
Duccio Medini, BioForge, United States
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Development of VSV-vector based vaccine against H5N1 avian influenza by targeting both H5N1 hemagglutinin and matrix protein 2
Zhujun Ao, University of Manitoba, Canada
Title : A novel responsive microneedle platform for reliable drug and vaccine delivery
Huanhuan Li, Queen’s University Belfast, United Kingdom
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Comparative efficacy of different H9N2 avian influenza virus inactivated vaccines using some commercially available adjuvants for superior control in broilers
Ayman H M El Deeb, Cairo University, Egypt
Title : Structure-based design and development of next-generation Respiratory Syncytial Virus (RSV) vaccine
Lei Chen, Yikang Biotech Suzhou Co., Ltd, China
Title : Unmasking urban immunization inequities: A cross-sectional LQAS analysis of zero-dose drivers in slum and non-slum settings of Uttar Pradesh, India
Ashish Kumar Maurya, John Snow India, India